2027 NCODA Global Oncology & Haematology Congress
March 10, 2027 | 9:00 AM EST
- Home
- Clinical Resources Search
- PQI: Niraparib (Zejula®): Dose Modifications Based on Weight and Platelet Counts
Niraparib (Zejula®): Dose Modifications Based on Weight and Platelet Counts
About this PQI
The purpose of this PQI is to highlight key criteria for appropriate monitoring, dosing, and administration to improve the dispensing and management of patients taking niraparib.
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Gedatolisib Combination Therapy for Locally Advanced or Metastatic Breast Cancer
Last Updated: 10/15/2026
PQI: Cardiovascular Risk associated with Androgen Deprivation Therapy (ADT) in Prostate Cancer
Last Updated: 10/08/2026
PQI: Administration of Subcutaneous Isatuximab-irfc (SARCLISA ESCENA) via the CirCLIQ On-Body Delivery System
Last Updated: 10/08/2026
PQI: Relacorilant (LIFYORLI) and Albumin-Bound Paclitaxel (Nab-Paclitaxel) for Platinum-Resistant Ovarian Cancer
Last Updated: 09/09/2026
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Inavolisib (Itovebi) Patient Management
Last Updated: 08/01/2026
PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia
Last Updated: 06/30/2026
PQI in Action: Capivasertib (Truqap) Patient Management
Last Updated: 05/06/2026
PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)
Last Updated: 04/01/2026
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S11 E8: The Future of Oncology
Last Updated: 10/18/2026
S11 E9: Fungi, Facts, and Cancer Care: Exploring Medicinal Mushrooms
Last Updated: 10/18/2026
S11 E6: Finding the Heart of Oncology
Last Updated: 10/18/2026
S11 E7: Your Health Story in One Place
Last Updated: 10/18/2026
Toolkit
Toolkit
Toolkit: Simplify CLL Tracking in Oncology Practices
Last Updated: 10/15/2025
Toolkit: Optimize CLL Care in Epic
Last Updated: 10/15/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Elranatamab
Last Updated: 01/06/2026
Treatment Support Kit: Bispecific (T-Cell Engager)
Last Updated: 12/12/2025
Treatment Support Kit: Zanidatamab-hrii
Last Updated: 09/28/2025
Treatment Support Kit: Avutometinib and Defactinib
Last Updated: 08/06/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 10/18/2026
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Last Updated: 10/18/2026
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Last Updated: 10/18/2026
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Last Updated: 10/18/2026
Patient Education Sheet
Patient Education Sheet
PQI
PQI in Action
Niraparib
Last Updated: 01/07/2026
Abiraterone and Niraparib
Last Updated: 01/07/2026
PQI: PARP Inhibitor Eligibility in Ovarian Cancer
Last Updated: 09/06/2023
PQI in Action: Multidisciplinary Management of Advanced Ovarian Cancer Patients within Medically Integrated Pharmacy Practices
Last Updated: 11/01/2019
Patient Education Sheet
PQI
PQI in Action
Niraparib
Last Updated: 01/07/2026
PQI: PARP Inhibitor Eligibility in Ovarian Cancer
Last Updated: 09/06/2023
PQI in Action: Multidisciplinary Management of Advanced Ovarian Cancer Patients within Medically Integrated Pharmacy Practices
Last Updated: 11/01/2019
PQI Podcast
PQI
Patient Education Sheet
PQI
S11 E9: Fungi, Facts, and Cancer Care: Exploring Medicinal Mushrooms
Last Updated: 10/18/2026
PQI: Gedatolisib Combination Therapy for Locally Advanced or Metastatic Breast Cancer
Last Updated: 10/15/2026
Tocilizumab (Actemra)
Last Updated: 10/12/2026
PQI: Relacorilant (LIFYORLI) and Albumin-Bound Paclitaxel (Nab-Paclitaxel) for Platinum-Resistant Ovarian Cancer
Last Updated: 09/09/2026